Genetic Disorders

11 registered clinical trials studyying Genetic Disorders — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Intensive Multimodal Neurorehabilitation Targeting Neuroplasticity in Pediatric Neurodevelopmental and Chromos NCT07493096	Healing Hope International	—
Recruiting	Whole Exome Sequencing and Whole Genome Sequencing for Nonimmune Fetal/Neonatal Hydrops NCT03911531	Thomas Jefferson University	—
Completed	Clinical Implementation of Carrier Status Using Next Generation Sequencing NCT01902901	Kaiser Permanente	N/A
Completed	Phase II, Randomized, Placebo-controlled Trial in Patients With Charcot-marie-tooth Disease Type 1A NCT01401257	Pharnext S.C.A.	Phase 2
Completed	A Study of the Safety and Immunogenicity of Repeated rhC1INH Administration NCT00851409	Pharming Technologies B.V.	Phase 2
Completed	Face Anthropometric Pattern Recognition Technology for Computer Aided Diagnosis of Human Genetic Disorders. NCT00705055	Carmel Medical Center	—
Completed	Recombinant Human C1 Inhibitor for the Treatment of Acute Attacks in Patients With Hereditary Angioedema NCT00262301	Pharming Technologies B.V.	Phase 3
Completed	Recombinant Human C1 Inhibitor for the Treatment of Acute Attacks in Patients With Hereditary Angioedema NCT00262288	Pharming Technologies B.V.	Phase 2 / Phase 3
Completed	Recombinant Human C1 Inhibitor for the Treatment of Acute Attacks in Patients With Hereditary Angioedema NCT00261053	Pharming Technologies B.V.	Phase 2
Completed	Allogeneic Bone Marrow Transplantation for the Treatment of Genetic Disorders of Erythropoiesis NCT00578435	Memorial Sloan Kettering Cancer Center	Phase 2
Unknown	Reproducibility of the Array-Based Comparative Genomic Hybridization (aCGH) System Using Whole Blood Samples NCT00214448	Abbott Molecular	—